Generalized accumulation of neutral glycosphingolipids with GM2 ganglioside accumulation in the brain. Sandhoff's disease (variant of Tay-Sachs disease)

William Krivit; Robert J. Desnick; J. Lee; J. Moller; Francis Wright; Charles C. Sweeley; Paul D. Snyder; Harvey L. Sharp

doi:10.1016/0002-9343(72)90082-4

Generalized accumulation of neutral glycosphingolipids with G_M2 ganglioside accumulation in the brain. Sandhoff's disease (variant of Tay-Sachs disease)

William Krivit, Robert J. Desnick, J. Lee, J. Moller, Francis Wright, Charles C. Sweeley, Paul D. Snyder, Harvey L. Sharp

Pediatric Cardiology

Research output: Contribution to journal › Article › peer-review

38 Scopus citations

Abstract

Recently, an inborn error of glycosphingolipid metabolism was described in which activities of beta-N-acetylhexosaminidase A and B were totally deficient. This resulted in the accumulation of two neutral glycosphingolipids, globoside and asialo G_M2 ganglioside in the brain. The systemic storage of a particular type of glycosphingolipid results in specific anatomic and pathophysiologic manifestations. Our patient had cardiovascular symptoms prior to the development of signs of central nervous system degeneration. Multiple lamellar cytoplasmic inclusion bodies were visualized under electron microscopy in every tissue examined. The diagnosis was confirmed by extensive biochemical analysis of tissue glycosphingolipids. Biochemical diagnosis during life can be accomplished by the demonstration of elevated levels of globoside^* * The use of the term globoside indicates the presence of galactosamine (GalNAc), galactose (Gal), glucose (Glc), sphingosine base and fatty acid in molar ratio of 1:2:1:1:1, and assignment of the galNAc to the terminal position, but does not indicate the stereochemistry and linkages of the respective sugar moieties. in plasma and urinary sediment as well as deficient activities of hexosaminidase A and B.

Original language	English (US)
Pages (from-to)	763-770
Number of pages	8
Journal	The American Journal of Medicine
Volume	52
Issue number	6
DOIs	https://doi.org/10.1016/0002-9343(72)90082-4
State	Published - Jun 1972

Bibliographical note

Funding Information:
From the Department of Pediatrics, the Dight Institute for Human Genetics, and the Departments of Pathology and Neurology of the University of Minnesota Medical School, Minneapolis, Minnesota, and the Department of Biochemistry, Michigan State University, East Lansing, Miichigan. This study was supported by grants from the U.S. Public Health Service (AM14470, CA08101 and CA08832), the National Cystic Fibrosis Foundatio,n and the General Resea.rch Support Program, University of Minnesota. Requests for reprints should be addressed to Dr. William Krivit, Department of Pediatrics, University of Minnesota Medical School, Box 284, Mayo Memorial Building, Minneapolis, Minnesota 55455. Manuscript received June 21, 1971; revised September 8, 1971.

Publisher link

10.1016/0002-9343(72)90082-4

Find It

Find It at U of M Libraries

Cite this

@article{17131e31dc0a4bb78dd0749f151b1941,

title = "Generalized accumulation of neutral glycosphingolipids with GM2 ganglioside accumulation in the brain. Sandhoff's disease (variant of Tay-Sachs disease)",

abstract = "Recently, an inborn error of glycosphingolipid metabolism was described in which activities of beta-N-acetylhexosaminidase A and B were totally deficient. This resulted in the accumulation of two neutral glycosphingolipids, globoside and asialo GM2 ganglioside in the brain. The systemic storage of a particular type of glycosphingolipid results in specific anatomic and pathophysiologic manifestations. Our patient had cardiovascular symptoms prior to the development of signs of central nervous system degeneration. Multiple lamellar cytoplasmic inclusion bodies were visualized under electron microscopy in every tissue examined. The diagnosis was confirmed by extensive biochemical analysis of tissue glycosphingolipids. Biochemical diagnosis during life can be accomplished by the demonstration of elevated levels of globoside* * The use of the term globoside indicates the presence of galactosamine (GalNAc), galactose (Gal), glucose (Glc), sphingosine base and fatty acid in molar ratio of 1:2:1:1:1, and assignment of the galNAc to the terminal position, but does not indicate the stereochemistry and linkages of the respective sugar moieties. in plasma and urinary sediment as well as deficient activities of hexosaminidase A and B.",

author = "William Krivit and Desnick, {Robert J.} and J. Lee and J. Moller and Francis Wright and Sweeley, {Charles C.} and Snyder, {Paul D.} and Sharp, {Harvey L.}",

note = "Funding Information: From the Department of Pediatrics, the Dight Institute for Human Genetics, and the Departments of Pathology and Neurology of the University of Minnesota Medical School, Minneapolis, Minnesota, and the Department of Biochemistry, Michigan State University, East Lansing, Miichigan. This study was supported by grants from the U.S. Public Health Service (AM14470, CA08101 and CA08832), the National Cystic Fibrosis Foundatio,n and the General Resea.rch Support Program, University of Minnesota. Requests for reprints should be addressed to Dr. William Krivit, Department of Pediatrics, University of Minnesota Medical School, Box 284, Mayo Memorial Building, Minneapolis, Minnesota 55455. Manuscript received June 21, 1971; revised September 8, 1971.",

year = "1972",

month = jun,

doi = "10.1016/0002-9343(72)90082-4",

language = "English (US)",

volume = "52",

pages = "763--770",

journal = "The American Journal of Medicine",

issn = "0002-9343",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Generalized accumulation of neutral glycosphingolipids with GM2 ganglioside accumulation in the brain. Sandhoff's disease (variant of Tay-Sachs disease)

AU - Krivit, William

AU - Desnick, Robert J.

AU - Lee, J.

AU - Moller, J.

AU - Wright, Francis

AU - Sweeley, Charles C.

AU - Snyder, Paul D.

AU - Sharp, Harvey L.

N1 - Funding Information: From the Department of Pediatrics, the Dight Institute for Human Genetics, and the Departments of Pathology and Neurology of the University of Minnesota Medical School, Minneapolis, Minnesota, and the Department of Biochemistry, Michigan State University, East Lansing, Miichigan. This study was supported by grants from the U.S. Public Health Service (AM14470, CA08101 and CA08832), the National Cystic Fibrosis Foundatio,n and the General Resea.rch Support Program, University of Minnesota. Requests for reprints should be addressed to Dr. William Krivit, Department of Pediatrics, University of Minnesota Medical School, Box 284, Mayo Memorial Building, Minneapolis, Minnesota 55455. Manuscript received June 21, 1971; revised September 8, 1971.

PY - 1972/6

Y1 - 1972/6

N2 - Recently, an inborn error of glycosphingolipid metabolism was described in which activities of beta-N-acetylhexosaminidase A and B were totally deficient. This resulted in the accumulation of two neutral glycosphingolipids, globoside and asialo GM2 ganglioside in the brain. The systemic storage of a particular type of glycosphingolipid results in specific anatomic and pathophysiologic manifestations. Our patient had cardiovascular symptoms prior to the development of signs of central nervous system degeneration. Multiple lamellar cytoplasmic inclusion bodies were visualized under electron microscopy in every tissue examined. The diagnosis was confirmed by extensive biochemical analysis of tissue glycosphingolipids. Biochemical diagnosis during life can be accomplished by the demonstration of elevated levels of globoside* * The use of the term globoside indicates the presence of galactosamine (GalNAc), galactose (Gal), glucose (Glc), sphingosine base and fatty acid in molar ratio of 1:2:1:1:1, and assignment of the galNAc to the terminal position, but does not indicate the stereochemistry and linkages of the respective sugar moieties. in plasma and urinary sediment as well as deficient activities of hexosaminidase A and B.

AB - Recently, an inborn error of glycosphingolipid metabolism was described in which activities of beta-N-acetylhexosaminidase A and B were totally deficient. This resulted in the accumulation of two neutral glycosphingolipids, globoside and asialo GM2 ganglioside in the brain. The systemic storage of a particular type of glycosphingolipid results in specific anatomic and pathophysiologic manifestations. Our patient had cardiovascular symptoms prior to the development of signs of central nervous system degeneration. Multiple lamellar cytoplasmic inclusion bodies were visualized under electron microscopy in every tissue examined. The diagnosis was confirmed by extensive biochemical analysis of tissue glycosphingolipids. Biochemical diagnosis during life can be accomplished by the demonstration of elevated levels of globoside* * The use of the term globoside indicates the presence of galactosamine (GalNAc), galactose (Gal), glucose (Glc), sphingosine base and fatty acid in molar ratio of 1:2:1:1:1, and assignment of the galNAc to the terminal position, but does not indicate the stereochemistry and linkages of the respective sugar moieties. in plasma and urinary sediment as well as deficient activities of hexosaminidase A and B.

UR - http://www.scopus.com/inward/record.url?scp=0015348263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015348263&partnerID=8YFLogxK

U2 - 10.1016/0002-9343(72)90082-4

DO - 10.1016/0002-9343(72)90082-4

M3 - Article

C2 - 5030173

AN - SCOPUS:0015348263

SN - 0002-9343

VL - 52

SP - 763

EP - 770

JO - The American Journal of Medicine

JF - The American Journal of Medicine

IS - 6

ER -